COSENTYX (secukinumab)

**Product type:** Human Prescription Drug

**Active ingredient:** SECUKINUMAB

**Strength:** 25 mg/mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Novartis Pharmaceuticals Corporation

**Marketing category:** BLA (BLA761349)

**Pharmacologic class:** Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]